Two-year comparison of safety and efficacy of atorvastatin and lovastatin

被引：0
|
作者：
BakkerArkema, RG [1 ]
Shurzinske, L [1 ]
Davidson, M [1 ]
McKenney, J [1 ]
Stein, E [1 ]
Schrott, H [1 ]
Black, DM [1 ]
机构：
[1] DIV WARNER LAMBERT CO,PARKE DAVIS PHARMACEUT RES,ANN ARBOR,MI
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia
    Davidson, M
    McKenney, J
    Stein, E
    Schrott, H
    BakkerArkema, R
    Fayyad, R
    Black, D
    [J]. PERFUSION, 1997, 10 (10): : 344 - 352
  • [2] Comparison of one-year efficacy and safety of Atorvastatin versus Lovastatin in primary hypercholesterolemia
    Davidson, M
    McKenney, J
    Stein, E
    Schrott, H
    BakkerArkema, R
    Fayyad, R
    Black, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (11): : 1475 - 1481
  • [3] Two-year safety and efficacy of once-daily extended-release macin/lovastatin in patients with hypercholesterolemia.
    Kashyap, ML
    Stanek, EJ
    Simmons, PD
    McGovern, ME
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1434 - 1434
  • [4] Two-year interim safety and efficacy of pegvaliase in Japanese adults with phenylketonuria
    Ishige, Mika
    Ito, Tetsuya
    Hamazaki, Takashi
    Kuwahara, Mitsuhiro
    Lee, Lawrence
    Shintaku, Haruo
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 140 (03)
  • [5] Two-year efficacy and safety of moderately-low-carbohydrate diet
    Yamada, Satoru
    Shimada, Mariko
    Tabata, Mitsuhisa
    Izumi, Hisa
    Nakajima, Chikako
    Uchida, Junichi
    Irie, Junichiro
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S76 - S76
  • [6] Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Bourdin, Arnaud
    Busse, William W.
    Ferguson, Gary T.
    Brooks, Laura
    Barker, Peter
    Martin, Ubaldo J.
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 : 401 - 413
  • [7] LOVASTATIN 5-YEAR SAFETY AND EFFICACY STUDY
    DAVIGNON, J
    XHIGNESSE, M
    MAILLOUX, H
    FROHLICH, J
    HAYDEN, ML
    VANETTA, H
    MISHKEL, MA
    MCQUEEN, MJ
    TAN, MH
    WOLFE, B
    NIKKILA, E
    TIKKANEN, MJ
    OJALA, JP
    HELVE, E
    DUJOVNE, CA
    HORNIMAN, S
    GOLDBERG, I
    GINSBERG, H
    GOLDBERG, R
    FARKAS, R
    HUNNINGHAKE, D
    BELL, L
    HELGREN, R
    KNOPP, R
    MCGINNIS, B
    KWITEROVICH, P
    GOLDBERG, A
    BLOOM, A
    MILLER, V
    LAROSA, J
    STOY, DB
    GASPARIS, G
    SCHONFELD, G
    GOLDBERG, A
    ANDERSON, C
    DILLINGHAM, M
    STEINBERG, D
    WITZTUM, J
    KELLY, N
    WEBB, H
    STEIN, EA
    LAMKIN, GE
    LEES, RS
    LEES, AM
    STEIN, SW
    BRENNAN, D
    ILLINGWORTH, DR
    BACON, SR
    GOTTO, AM
    JONES, PH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (09) : 1079 - 1087
  • [8] Safety in the 2015 two-year guidelines
    Ellefson, Julie
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [9] The CURVES study - A comparison of the dose efficacy of atorvastatin with pravastatin, simvastatin, fluvastatin and lovastatin
    Kafonek, S
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 : S232 - S232
  • [10] The CURVES study: A comparison of the dose efficacy of atorvastatin with simvastatin, pravastatin, lovastatin, and fluvastatin
    Kafonek, S
    [J]. XIII WORLD CONGRESS OF CARDIOLOGY: FREE PAPERS, 1998, : 1003 - 1007
12345